| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/07/2002 | US20020028791 Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2420667A1 Quinoline-(c=o)-(di-,tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | CA2418041A1 Pyrrolidine derivatives and their use as chymase inhibitor |
| 03/06/2002 | EP1184035A2 Use of growth hormone secretagogues for treatment of physical performance decline |
| 03/06/2002 | EP1183274A1 Method and compounds for inhibiting activity of serine elastases |
| 03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
| 03/06/2002 | EP0960213A4 A METHOD OF DETECTING PROTEIN BY IMMUNO-aRNA |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6352976 Selective inhibitors of MMP-12 |
| 03/05/2002 | US6352824 Redox reversible bipyridyl-osmium complex conjugates |
| 02/28/2002 | WO2002016412A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | WO2002016408A2 Gpe analogs |
| 02/28/2002 | WO2002016407A2 Sh2 domain binding inhibitors |
| 02/28/2002 | WO2002016406A1 METAL ION ASSISTED N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER ISOMER RESOLUTION |
| 02/28/2002 | WO2002016405A1 S-nitrosothiols and their use as medicaments for cardiovascular diseases |
| 02/28/2002 | WO2002016404A1 Cyclic peptide derivative |
| 02/28/2002 | WO2002015922A2 New uses for amino acid anticonvulsants for treatment of pain |
| 02/28/2002 | WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/28/2002 | WO2001027261A3 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026034 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 02/28/2002 | US20020026033 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 02/28/2002 | US20020026032 3, 5-Dioxa-12-azawurtzitane compound and process of preparing same |
| 02/28/2002 | US20020025980 Single morphic forms of metalloproteinase inhibitors |
| 02/28/2002 | US20020025935 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/28/2002 | US20020025549 Synthesis and recovery of aspartame involving enzymatic deformylation step |
| 02/28/2002 | US20020025401 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 02/28/2002 | DE10040380A1 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties |
| 02/28/2002 | CA2740815A1 New uses for amino acid anticonvulsants |
| 02/28/2002 | CA2419870A1 Sh2 domain binding inhibitors |
| 02/28/2002 | CA2418006A1 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | CA2355921A1 Isolated antioxidant peptides from casein and methods for preparing, isolating, and identifying antioxidant peptides |
| 02/27/2002 | EP1182263A1 Process for detecting threonine/serine kinase activity |
| 02/27/2002 | EP1182207A2 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/27/2002 | EP1181309A1 Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b) |
| 02/27/2002 | EP1181055A2 Enzyme-activated anti-tumor prodrug compounds |
| 02/27/2002 | EP0817770B1 Nonpeptides as tachykinin antagonists |
| 02/27/2002 | EP0790982B1 Methods of synthesis of peptidyl argininals |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337403A Active monopeptide prepared from active blood polypeptide and its prepn. activity and sequence |
| 02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350741 Inhibitors of interleukin-1β converting enzyme |
| 02/26/2002 | US6350430 Melanocortin receptor ligands and methods of using same |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/21/2002 | WO2002014543A2 Process for detecting enzyme activity in an immunoassay |
| 02/21/2002 | WO2002014542A2 Process for detecting serine/threonine kinase activity |
| 02/21/2002 | WO2002014354A1 Water soluble thiazolyl peptide derivatives |
| 02/21/2002 | WO2002014349A2 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/21/2002 | WO2002013848A1 Highly homogeneous molecular markers for electrophoresis |
| 02/21/2002 | WO2001090063A3 Prodrug of an ice inhibitor |
| 02/21/2002 | WO2001055175A3 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/21/2002 | WO2001042225A3 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 02/21/2002 | US20020022742 Salt forms of an HIV protease inhibitor |
| 02/21/2002 | US20020022659 For therapy of viral infection |
| 02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/21/2002 | US20020022623 A substituted hydroxyethylene compound useful for treating Alzheimer's disease, mild cognitive impairment, Down's syndrome, herediatary cerebral hemmorrhage with amyloidosis, degenerative dementia |
| 02/21/2002 | US20020022621 Benzodiazepinone beta -amyloid inhibitors: arylacetamidoalanyl derivatives |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | US20020022596 Novel malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them |
| 02/21/2002 | US20020022243 Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | DE10025379A1 Bestimmung von NAALADase-Inhibitoren Determination of NAALADase inhibitors |
| 02/21/2002 | CA2387002A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/20/2002 | EP1180121A1 Long lasting insulinotropic peptides |
| 02/20/2002 | EP1180116A2 Fap-activated anti-tumor compounds |
| 02/20/2002 | EP1180115A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents |
| 02/20/2002 | CN1336934A Bis-amino acid sulfonamides containing N-terminally a substituted benzyl group as HIV protease inhibitors |
| 02/19/2002 | US6348570 Tetrapeptides; diagnosing and monitoring inflammatory, nervous system, skin, cardiovascular, respiratory system, gastrointestinal, urogenital and immune disorders; evaluating inhibitors |
| 02/19/2002 | US6348568 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 02/19/2002 | US6348567 A peptide derived from streptokinase; therapy for nervous system disorders, cardiovascular diseases, autoimmune diseases, parkinson's/alzheimer's/huntington's diseases and inflammatory diseases |
| 02/19/2002 | US6348448 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/14/2002 | WO2002012270A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/14/2002 | WO2002012269A2 Pharmaceutical composition comprising an analgesic peptide |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | US20020019557 Synthesis of N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester using L-alpha-aspartyl-L- phenylalanine 1-methyl ester precursors |
| 02/14/2002 | US20020019429 Antiarthritic agents; osteoporosis |
| 02/14/2002 | US20020019403 Inhibit amyloid protein deposits |
| 02/14/2002 | US20020019371 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)- alkylaminocarbonyl)azetidine |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2418131A1 Peptides capable of functioning as mimotopes for estradiol analytes |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179008A2 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP0614379B1 Technetium-99m labeled peptides for imaging |
| 02/13/2002 | CN1335852A Novel depsipeptide compound |
| 02/13/2002 | CN1335851A Synthesis and recovery of aspartame involving enzymatic deformylation step |
| 02/12/2002 | US6346642 Mixed crystals comprising aspartame and aspartame derivative and process for producing the same |
| 02/12/2002 | US6346514 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 02/07/2002 | WO2002010124A2 Salt forms of an hiv protease inhibitor |
| 02/07/2002 | WO2002009711A1 Thrombin inhibitors |